– Making Morphology-Based Single-Cell Analysis via Ghost Cytometry® More Accessible –
ThinkCyte, a biotechnology company developing AI-driven cell analysis and sorting technology, is pleased to announce the launch of contract research service utilizing its proprietary AI-driven, label-free cell sorter, VisionSort.
Background of the Service Launch
In recent years, the life sciences field, including drug discovery, regenerative medicine, and cell therapy, has seen a growing need for detailed cell analysis at the single-cell level, as well as the analysis and sorting of cells with specific phenotypes. However, introducing and operating cutting-edge analytical technology within an organization’s own laboratory often poses challenges, such as instrument acquisition costs and the need to establish specialized operational expertise.
To address these challenges, ThinkCyte has launched this service to make our cell analysis and sorting using VisionSort more accessible to scientists. The service is designed to support flexible research needs, including pilot testing prior to instrument adoption and project-based analyses for specific research objectives, including studies intended for publication.
Key Features of the Service
Using the VisionSort installed in ThinkCyte’s laboratory, we will analyze and sort cell samples provided by customers.
- Label-free independent of existing markers: Utilizing ThinkCyte’s proprietary technology, “Ghost Cytometry,” the service enables AI-driven cell profiling and sorting based on high-definition morphological information without relying on conventional markers such as fluorescent antibody staining.
- Minimizing damage to cells: By sorting cells without staining and in a gentle environment using disposable microfluidic chips, the impact on live cells requiring subsequent cultivation or functional analysis is minimized.
Detailed Information and Inquiries
Under this service, ThinkCyte will individually propose optimal plans tailored to each customer’s research objectives and cell sample types. For service details, preliminary consultations, or quotation requests, please contact the dedicated inquiry address at crs@thinkcyte.com.
About ThinkCyte
ThinkCyte, founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development. The company’s flagship product, VisionSort, is the world’s first AI-based, dual-mode fluorescence and morphometric cell sorting platform and it partners with major global biopharmaceutical companies and leading academic research institutes to further drive groundbreaking research. For more information, please visit www.thinkcyte.com.
